Dynamics of anti-Strongyloides IgG antibody responses and implications for strongyloidiasis surveillance in rural Amazonians: A population-based panel data analysis
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0012967 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Fabiana M de Paula und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Investigação Médica LIM-06, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Strongyloidiasis, Immunoglobulin G, Antibodies, Helminth, Strongyloides stercoralis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background Human strongyloidiasis was recently incorporated into the World Health Organization roadmap for neglected tropical diseases targeted for control in 2021−2030. However, the prevalence, incidence, and clinical burden of Strongyloides stercoralis infection remain understudied in remote communities across the Amazon due to its chronic nature, usually with absent or unspecific clinical manifestations, and the lack of practical and sensitive diagnostics for large-scale use. Here, we apply repeated antibody testing to estimate the prevalence of anti- Strongyloides IgG responses and identify incident infections in five farming settlements in the Amazonas State of Brazil. Methodology/Principal findings We used an in-house enzyme immunoassay, with a S. venezuelensis larval extract as the solid-phase antigen, to detect specific IgG antibodies in 898 plasma samples collected during consecutive cross-sectional surveys over 4 years from 426 study participants aged >3 months, with an average of 35.9 years. Overall, 465 (51.8%) samples tested positive. However, only two infections that had been detected by fecal microscopy at survey 1 (March-May 2010) were treated with ivermectin. Antibody prevalence rose from 45.9% in 2010 to 61.1% in 2013, consistent with an increased (re)exposure to infective larvae over time. On average, there were 24.5 seroconversion events (a proxy of recent exposure to infection) per 100 person-years of follow-up, with 18.1 seroreversion events per 100 person-years. Nearly all participants with high antibody levels (i.e., above the median absorbance of seropositive tests) remained seropositive over the next years, with a single instance of high-to-nil antibody transition. Long-lasting high-level IgG responses were most likely due to frequent re-exposure to infective S. stercoralis larvae, chronic carriage of adult worms in the absence of treatment, or both. Conversely, over one-third of participants with low anti- Strongyloides antibody levels had transient IgG responses and seroreversed within 12 months. Conclusions/Significance The results support the use of repeated antibody testing for monitoring temporal changes in S. stercoralis transmission in remote populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratório de Investigação Médica LIM-06, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
- Instituto de Medicina Tropical de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
- Department of Medicine, Federal University of São Carlos, São Carlos, São Paulo, Brazil.
- Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
- Department of Dermatological, Infectious and Parasitic Diseases, Faculty of Medicine of São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.
- Department of Parasitology, Microbiology and Immunology, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
ORCID-Profile: Marcelo U Ferreira
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação para a Ciência e a Tecnologia
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
de Paula, F. M., Gomes, B. B., Meisel, D. M. C. L., da-Silva Nunes, M., Cavasini, C. E., Scopel, K. K. G., Gryschek, R. C. B., & Ferreira, M. U. (2025). Dynamics of anti-Strongyloides IgG antibody responses and implications for strongyloidiasis surveillance in rural Amazonians: A population-based panel data analysis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012967
Vancouver
de Paula FM, Gomes BB, Meisel DMCL, da-Silva Nunes M, Cavasini CE, Scopel KKG, et al. Dynamics of anti-Strongyloides IgG antibody responses and implications for strongyloidiasis surveillance in rural Amazonians: A population-based panel data analysis. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012967
BibTeX
@article{dePaula2025,
author = {de Paula, Fabiana M and Gomes, Bruna B and Meisel, Dirce Mary C L and da-Silva Nunes, Mônica and Cavasini, Carlos E and Scopel, Kézia K G and Gryschek, Ronaldo C B and Ferreira, Marcelo U},
title = {Dynamics of anti-Strongyloides IgG antibody responses and implications for strongyloidiasis surveillance in rural Amazonians: A population-based panel data analysis},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0012967}
}
EUVIMED